CRF Connect Logo

Coronary

Devices and Complications Learning Series

DES and BRS

Advertisement

Coronary >
DES and BRS

Episodes

Novel Solutions for High Bleeding Risk Patients
Novel Solutions for High Bleeding Risk Patients
18 min.
Does Polymer Coating Matter? Biodegradable vs Durable vs Polymer-Free
Does Polymer Coating Matter? Biodegradable vs Durable vs Polymer-Free
9 min.
DES to Allow Adaptive Remodeling
DES to Allow Adaptive Remodeling
19 min.
The Modern Era of Ultra-Thin Struts – Is It a True Advantage?
The Modern Era of Ultra-Thin Struts – Is It a True Advantage?
9 min.
The Future of Combined Technology – DES Plus DCB
The Future of Combined Technology – DES Plus DCB
12 min.
Recurrent Revascularization After Treatment Of Drug-Eluting Stent Restenosis With Drug-Coated Balloon, Plain Balloon Or Drug-Eluting Stent  10-Year Results From the Randomized ISAR-DESIRE 3 Trial
Recurrent Revascularization After Treatment Of Drug-Eluting Stent Restenosis With Drug-Coated Balloon, Plain Balloon Or Drug-Eluting Stent 10-Year Results From the Randomized ISAR-DESIRE 3 Trial
15 min.
Dedicated Bifurcation Stents: Why Did They Disappear, and What’s on the Horizon?
Dedicated Bifurcation Stents: Why Did They Disappear, and What’s on the Horizon?
17 min.
Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial
Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial
24 min.
Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial
Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial
14 min.
The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration
The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration
18 min.
First Human Use of a ‘Hybrid’ (Polymer + Metal) Coronary Drug-Eluting Stent: The IonMAN Study
First Human Use of a ‘Hybrid’ (Polymer + Metal) Coronary Drug-Eluting Stent: The IonMAN Study
11 min.
A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study
A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study
13 min.
Yes: There Is Always Room For Better Stents
Yes: There Is Always Room For Better Stents
24 min.
No: Current DES Are Better Than Ever
No: Current DES Are Better Than Ever
6 min.
MeRes Thin-Strut Sirolimus-eluting BRS
MeRes Thin-Strut Sirolimus-eluting BRS
7 min.
Cre8 Amphilimus: Polymer-Free Drug-Eluting Coronary  Stent
Cre8 Amphilimus: Polymer-Free Drug-Eluting Coronary Stent
8 min.
Abluminus Hybrid DES+DCB Technology
Abluminus Hybrid DES+DCB Technology
6 min.
Ionir Ultrathin Polymer Mesh Coronary DES
Ionir Ultrathin Polymer Mesh Coronary DES
6 min.
DESyne BDS Plus: Triple Drug Coronary Stent Eluting Two anticoagulants and Sirolimus
DESyne BDS Plus: Triple Drug Coronary Stent Eluting Two anticoagulants and Sirolimus
5 min.
Dynamx Bioadaptor Coronary Stent Technology Designed to Restore Vasomotion
Dynamx Bioadaptor Coronary Stent Technology Designed to Restore Vasomotion
7 min.
Does It Matter What Stent I Use in a HBR Patient?
Does It Matter What Stent I Use in a HBR Patient?
8 min.
DynamX Bioadaptor and Desyne BDS+
DynamX Bioadaptor and Desyne BDS+
6 min.
IoNir Hybrid Coronary DES System
IoNir Hybrid Coronary DES System
6 min.
Safety and Performance of a Sirolimus Eluting Resorbable Coronary Magnesium Scaffold (DREAMS 3G): The BIOMAG-1 FIH Trial
Safety and Performance of a Sirolimus Eluting Resorbable Coronary Magnesium Scaffold (DREAMS 3G): The BIOMAG-1 FIH Trial
7 min.
Rotablation and Cutting Balloon to Release Stuck Externalized RG3 in an Ostial RCA Occluded 1st Generation DES
Rotablation and Cutting Balloon to Release Stuck Externalized RG3 in an Ostial RCA Occluded 1st Generation DES
10 min.
Drug-Eluting Balloon Angioplasty in Chronic Total Occlusions to Improve the Distal Vessel
Drug-Eluting Balloon Angioplasty in Chronic Total Occlusions to Improve the Distal Vessel
5 min.